Clinical outcomes of neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian carcinoma

European Journal of Gynaecological Oncology

Volumn 27, Issue 1, 2006, Pages 25-28

  Giannopoulos, T ^a,c   Butler Manuel, S ^a   Taylor, A ^a   Ngeh, N ^b   Thomas, H ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b EAST SURREY HOSPITAL   (United Kingdom)

^c Royal Surrey Hospital   (United Kingdom)

Author keywords

Advanced Ovarian Cancer; Interval debulking surgery; Morbidity

Indexed keywords

PACLITAXEL; PLATINUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG SENSITIVITY; FEMALE; HOSPITAL COST; HUMAN; INOPERABLE CANCER; INTENSIVE CARE UNIT; INTERVAL CYTOREDUCTIVE SURGERY; LAPAROSCOPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OVARY CARCINOMA; PELVIS LYMPHADENECTOMY; PRIMARY CYTOREDUCTIVE SURGERY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644965598     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Griffiths T.C., Parker L.M., Fuller A.F.: "Role of cytoreductive surgical treatment in the management of advanced ovarian cancer". Cancer Treat. Rep., 1979, 63, 235.
2. Michel G., DeiLaco P., Castaigne D.: "Extensive cytoreductive surgery in advanced ovarian carcinoma". Eur. J. Gynaecol. Oncol., 1997, 18, 9.
3. Hacker N.F., Berek J.S., Lagasse L.D.: "Primary cytoreductive surgery for epithelial ovarian cancer". Obstet. Gynecol., 1983, 61, 413.
4. Hoskins W.J., McGuire W.P., Brady M.F.: "The effect of the diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma". Am. J. Obstet. Gynecol., 1994, 170, 974.
5. Eisenkop S.M., Friedman R.L., Wang H.J.: "Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study". Gynecol. Oncol., 1998, 69, 103.
6. Shimada M., Kigawa J., Minagawa Y.: "Significance of cytoreductive surgery including bowel resection for patients with advanced ovarian cancer". Am. J. Clin. Oncol., 1999, 22, 481.
7. Cuidoizi F., Ball J.H.: "Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer". Gynecol. Oncol., 1994, 53, 326.
8. Shimada M., Ktgawa J., Mtnagawa Y.: "Significance of cytoreductive surgery including bowel resection for patients with advanced ovarian cancer". Am. J. Clin. Oncol. 1999, 22, 481.
9. Donato D., Angelides A., Irani H.: "Infectious complications after gastrointestinal surgery in patients with ovarian carcinoma and malignant ascites". Gynecol. Oncol., 1992, 44, 40.
10. Vergote I.B., De Wever I., Decloedt J.: "Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients". Gynecol Oncol., 1998, 71, 431.
11. Jemal A., Tiwari C., Murray T.: "Cancer statistics, 2004". CA Cancer J. Clin., 2004, 54.
12. Boente P., Chi S., Hoskins J.: "The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery". Semin. Oncol., 1998, 25, 326.
13. Canis M., Rabischong B., Botchorishvili R.: "Risk of spread of ovarian cancer after laparoscopic surgery". Curr. Opin. Obstet. Gynecol., 2001, 13, 9.
14. Ansquer Y., Leblanc E., Clough K.: "Neoadjuvant chemotherapy for unresectable ovarian carcinoma". Cancer 2001, 91, 23.
15. Vergote I., De Wever I., Decloedt J.: "Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer". Semin. Oncol., 2000, 27, 31.
16. Jacob H., Gershenson M., Morris M.: " Neoadjuvant chemotherapy and interval Debulking for advanced epithelial ovarian cancer". Gynecol. Oncol., 1991, 42, 146.
17. Schwartz E., Rutherford J., Chambers T.: "Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival". Gynecol. Oncol., 1999, 72, 93.
18. Van der Burg L., Van Lent M., Buyse M.: "The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer". N. Engl. J. Med., 1995, 332.
19. Rose G., Nerenstone S., Brady F.: "Secondary surgical cytoreduction for advanced ovarian carcinoma". N. Engl. J. Med., 2004, 351, 2489.
20. Morice P., Dubernard G., Rey A.: "Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer". J. Am. Coll. Surg., 2003, 197, 955.
21. Rose G., Nerenstone S., Brady M.: "A phase III randomized study of interval secondary cytoreduction in patients with advanced stage ovarian carcinoma with suboptimal residual disease: a Gynecologic Oncology Group study". Proceedings of the American Association of Cancer Research, 2002, 802.
22. Vergote I., De Wever I., Tjalma W.: "Interval debulking surgery: an alternative for primary surgical debulking?". Semin. Surg. Oncol., 2000, 19, 49.
23. Shimada M., Kigawa J., Minagawa Y.: "Significance of cytoreductive surgery including bowel resection for patients with advanced ovarian cancer". Am. J. Clin. Oncol., 1999, 22, 481.
24. Jacob H., Gershenson M., Morris M.: "Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer". Gynecol. Oncol., 1991, 42, 146.
25. Morice P., Leblanc E., Narducci F., Pomel C., Pautier P., Chevalier A. et al.: "Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?". Gynecol. Obstet. Fertil., 2005, 33, 55.
26. Arwit E., Childers J., Atlas I.: "Neoadjuvant chemotherapy for advanced ovarian cancer". Int. J. Gynecol. Cancer, 1996, 6, 356.
27. Schwartz E., Rutherford, Champers A.: "Neoadjuvant chemotherapy for advanced ovarian cancer. Long-term survival". Gynecol. Oncol., 1999, 72, 93.
28. Van Dam A., DeCloedt J., Tjalma A., Buytaert P., Becquart D., Vergote I.: "Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: can this risk be reduced?". Am. J. Obstet. Gynecol., 181, 3, 536.
29. Morice P., Viala J., Pautier P.: "Port site metastasis after laparoscopic surgery for gynecological cancer. Report of 6 cases and surgical implications for prevention". J. Reprod. Med., 2000, 45, 837.
30. Canis M., Rabischong B., Botchorishvili R.: "Risk of spread of ovarian cancer after laparoscopic surgery". Curr. Opin. Obstet. Gynecol., 2001, 13, 9.
31. Vrscaj U., Rakar S.: "Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study". Eur. J. Gynaecol. Oncol., 2002, 23, 405.
32. Morice P., Dubernard G., Atallah D., Pautier P., Duvillard P., Castaigne D.: "Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer". J. Am. Coll. Surg., 2003, 197, 955.
33. Schwartz P., Rutherford J., Chambers T: "Induction chemotherapy for advanced ovarian cancer: Long-term survival". Gynecol. Oncol., 1999, 72, 93.
34. Surwit E., Childers J., Atlas I. et al.: "Neoadjuvant chemotherapy for advanced ovarian cancer". Int. J. Gynecol. Cancer, 1996, 6, 356.